The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms
Ren Jie Jin, Douglas W. Strand, Connor M. Forbes, Thomas Case, Justin M.M. Cates, Qi Liu, Marisol Ramirez-Solano, Ginger L. Milne, Stephanie Sanchez, Zunyi Y. Wang, Dale E. Bjorling, Nicole L. Miller, Robert J. Matusik
Dive into the research topics of 'The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms'. Together they form a unique fingerprint.